SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-071233
Filing Date
2021-05-24
Accepted
2021-05-24 16:34:36
Documents
12
Period of Report
2021-05-18
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2117426d1_8k.htm   iXBRL 8-K 34017
  Complete submission text file 0001104659-21-071233.txt   206367

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA nwbo-20210518.xsd EX-101.SCH 3178
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE nwbo-20210518_lab.xml EX-101.LAB 34592
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nwbo-20210518_pre.xml EX-101.PRE 22705
5 EXTRACTED XBRL INSTANCE DOCUMENT tm2117426d1_8k_htm.xml XML 3514
Mailing Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814
Business Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814 (240) 497-9024
NORTHWEST BIOTHERAPEUTICS INC (Filer) CIK: 0001072379 (see all company filings)

IRS No.: 943306718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35737 | Film No.: 21955454
SIC: 2834 Pharmaceutical Preparations